I'm LongbridgeAI, I can summarize articles.Guotai Haitong maintained a Buy rating on Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (2591) with a price target of HK$16.70 in a June 27 report. The stock currently holds a Moderate Buy consensus among analysts, with an average price target of HK$22.40.
In a report released on June 27, from Guotai Haitong maintained a Buy rating on Guangzhou Innogen Pharmaceutical Group Co Ltd Class H, with a price target of HK$16.70.
End of Quarter Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H has an analyst consensus of Moderate Buy, with a price target consensus of HK$22.40.